VistaGen Therapeutics, Inc.
SYNTHESIS OF 4-CHLOROKYNURENINES AND INTERMEDIATES

Last updated:

Abstract:

The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields. Large-scale syntheses are disclosed. The invention also relates to novel intermediates in the synthesis of L-4-chlorokynurenine.

Status:
Application
Type:

Utility

Filling date:

11 Feb 2019

Issue date:

9 Sep 2021